Advanced Search
Contact | Corporate | Help

Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema

Sponsors:
  • Vitreous -Retina- Macula Consultants of New York
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Retinal Vein Occlusion
Age Groups:
  • Child
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Ranibizumab (Lucentis )
Enrollment:
45

Additional information about NCT00403039.


SourceSolution © 2008-2012